Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy
A. Nascimento Osorio, Jordi Cantillo, Ana Camacho, et al.
Neurología (English Edition) (2018) Vol. 34, Iss. 7, pp. 469-481
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Pubertal induction therapy in pediatric patients with Duchenne muscular dystrophy
Giorgio Sodero, Clelia Cipolla, Donato Rigante, et al.
Journal of Pediatric Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 1
Non-invasive electromechanical cell-based biosensors for improved investigation of 3D cardiac models
Guido Caluori, Jan Přibyl, Martin Pešl, et al.
Biosensors and Bioelectronics (2018) Vol. 124-125, pp. 129-135
Closed Access | Times Cited: 75
A Dual Diagnosis of Okur–Chung Neurodevelopmental Syndrome and Becker Muscular Dystrophy: Inquiry Into the Lower Limits of Neurodevelopmental Functioning Attributable to Muscular Dystrophy
Victoria Liu, Eva Hanson, Joshua W Owens, et al.
Brain and Behavior (2025) Vol. 15, Iss. 2
Open Access
Caregivers and multidisciplinary team members’ perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study
Elise Schoefs, Thomas Desmet, Evelyn Lerinckx, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Uso de glucocorticoides en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Juan David Lasprilla Tovar, Norma Carolina Barajas Viracachá, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
Glucocorticoides y manejo cardíaco en pacientes con distrofia muscular de Duchenne
Edna Julieth Bobadilla-Quesada, Manuel Huertas-Quiñones, Juan David Lasprilla Tovar, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-13
Open Access
Recomendaciones de prescripción de ayudas técnicas en la rehabilitación de pacientes con distrofia muscular de Duchenne
Sandra Milena Castellar-Leones, Edicson Ruiz Ospina, Miguel Ángel Gutiérrez-Ramírez, et al.
Revista Ciencias de la Salud (2025) Vol. 23, Iss. Especial, pp. 1-19
Open Access
Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy: a scoping review
Marco Málaga, Aarón Rodríguez-Calienes, Fabian A. Chavez‐Ecos, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 3
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
Ilaria Andreana, Mathieu Repellin, Flavia Carton, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 278-278
Open Access | Times Cited: 21
Longitudinal study of multi-parameter quantitative magnetic resonance imaging in Duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients
Fei Peng, Huayan Xu, Yu Song, et al.
Journal of Neurology (2022) Vol. 270, Iss. 3, pp. 1439-1451
Closed Access | Times Cited: 10
Utilization of T1-Mapping for the pelvic and thigh muscles in Duchenne Muscular Dystrophy: a quantitative biomarker for disease involvement and correlation with clinical assessments
Fei Peng, Huayan Xu, Yu Song, et al.
BMC Musculoskeletal Disorders (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Mechatronics Design of a Gait-Assistance Exoskeleton for Therapy of Children with Duchenne Muscular Dystrophy
Jaime Arcos-Legarda, David Torres, Fredy Velez, et al.
Applied Sciences (2023) Vol. 13, Iss. 2, pp. 839-839
Open Access | Times Cited: 5
Generation of percentile curves for strength and functional abilities for boys with Duchenne muscular dystrophy
Mariana Angélica de Souza, Daiane Leite da Roza, Gabriela Barroso de Queiroz Davoli, et al.
Muscle & Nerve (2023) Vol. 68, Iss. 2, pp. 198-205
Closed Access | Times Cited: 5
Effectiveness of a 5-Week Virtual Reality Telerehabilitation Program for Children With Duchenne and Becker Muscular Dystrophy: Prospective Quasi-Experimental Study
María Rosa Baeza-Barragán, María Teresa Labajos Manzanares, Mercedes Cristina Amaya-Álvarez, et al.
JMIR Serious Games (2023) Vol. 11, pp. e48022-e48022
Open Access | Times Cited: 5
Acinetobacter baumannii Is a Risk Factor for Lower Respiratory Tract Infections in Children and Adolescents With a Tracheostomy
Joerg Grosse‐Onnebrink, Johanna Rudloff, Christina Keßler, et al.
The Pediatric Infectious Disease Journal (2019) Vol. 38, Iss. 10, pp. 1005-1009
Closed Access | Times Cited: 12
Role of Physical Therapy Intervention and Gene Therapy on Muscular Dystrophies, Current Status and Future Perspectives: A Narrative Review
Hafsa Abid, S. Mudasser Shah, Ali Najah Ahmed, et al.
Pakistan Journal of Health Sciences (2024), pp. 09-14
Open Access | Times Cited: 1
Physiotherapeutic Interventions for Patients With Rare Genetic Muscle-Wasting Disorders: A Systematic Review and Meta-Analysis
Abdullah Alzahrani
Cureus (2024)
Open Access | Times Cited: 1
Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States
Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino‐Klapac, et al.
Journal of Market Access & Health Policy (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 3
Development of a new instrument to evaluate gait characteristics of individuals with Duchenne Muscular Dystrophy: Gait Assessment Scale for Duchenne Muscular Dystrophy, and its validity and reliability
Güllü Aydın Yağcıoğlu, İpek Alemdaroğlu-Gürbüz, Semra Topuz, et al.
Early Human Development (2023) Vol. 185, pp. 105843-105843
Closed Access | Times Cited: 3
Confirmatory validation of the french version of the Duchenne Muscular Dystrophy module of the pediatric quality of life inventory (PedsQLTM3.0DMDfv)
Elisabeth Wallach, Virginie Ehlinger, Maëlle Biotteau, et al.
BMC Pediatrics (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Analysis of Long Noncoding RNAs-Related Regulatory Mechanisms in Duchenne Muscular Dystrophy Using a Disease-Related lncRNA-mRNA Pathway Network
Bing Xu, Chunlei Zheng
Genetics Research (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 4
Consenso colombiano para el seguimiento de pacientes con Distrofia muscular de Duchenne
Maritza Muñoz Rivas, Sandra Milena Castellar-Leones, Edicson Ruiz Ospina, et al.
Pediatría (2020) Vol. 52, Iss. 3, pp. 75-84
Open Access | Times Cited: 5
Current diagnosis and treatment of Duchenne muscular dystrophy
D. D. Gaynetdinova, А. А. Новоселова
Kazan medical journal (2020) Vol. 101, Iss. 4, pp. 530-537
Open Access | Times Cited: 5
Can simple and low-cost motor function assessments help in the diagnostic suspicion of Duchenne muscular dystrophy?
Aline Chacon Pereira, Alexandra Prufer de Queiroz Campos Araújo, Márcia Gonçalves Ribeiro
Jornal de Pediatria (2019) Vol. 96, Iss. 4, pp. 503-510
Open Access | Times Cited: 4
The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
T. A. Gremyakova, S. B. Artemyeva, Nato D. Vashakmadze, et al.
Neuromuscular Diseases (2022) Vol. 12, Iss. 2, pp. 10-18
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top